Open AccessTen‐year survival outcome of the nicotine transdermal patch with cognitive behavioural therapy
Author(s) -
Richmond Robyn L.,
Kehoe Linda
Publication year - 2007
Publication title -
australian and new zealand journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.946
H-Index - 76
eISSN - 1753-6405
pISSN - 1326-0200
DOI - 10.1111/j.1467-842x.2007.00062.x
Subject(s) - abstinence , nicotine patch , medicine , placebo , nicotine , smoking cessation , anesthesia , psychiatry , alternative medicine , pathology
Objective: To follow‐up abstainers from the end of their initial treatment over seven points to 10 years. Methods: In the original study there were 305 smokers who were recruited in a double‐blind randomised controlled trial. Those subjects who had remained continuously abstinent to seven years (n=20) were followed up to ascertain continuous smoking prevalence to 10 years. Main outcome measure was continuous abstinence. Results: At 10 years, the active nicotine patch group showed significantly higher continuous abstinence rates that were double those of the placebo group (7.9% vs. 2.6%, respectively). The high rate of relapse declined after six months. Conclusions: The nicotine patch leads to superior continuous abstinence over 10 years when compared with placebo. Public health implications: This is the longest follow‐up study of continuous smoking abstinence after cognitive behaviour treatment combined with the nicotine patch.